ECSP034570A - Formulacion de una solucion de inhalacion con una sal tiotropio - Google Patents

Formulacion de una solucion de inhalacion con una sal tiotropio

Info

Publication number
ECSP034570A
ECSP034570A EC2003004570A ECSP034570A ECSP034570A EC SP034570 A ECSP034570 A EC SP034570A EC 2003004570 A EC2003004570 A EC 2003004570A EC SP034570 A ECSP034570 A EC SP034570A EC SP034570 A ECSP034570 A EC SP034570A
Authority
EC
Ecuador
Prior art keywords
formulation
tiotropio
salt
inhalation solution
water
Prior art date
Application number
EC2003004570A
Other languages
English (en)
Inventor
Christel Schmelzer
Humke Barbara Niklaus
Petra Barth
Karin Drechsel
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP034570(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP034570A publication Critical patent/ECSP034570A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una formulación para inhalación exenta de gases propelentes de bromuro de tiotropio o monohidrato de bromuro de tiotropio, disuelto en agua o en una mezcla de agua y etanol, así como a los aerosoles inhalables exentos de gases propelentes resultantes de ella.
EC2003004570A 2000-10-31 2003-04-28 Formulacion de una solucion de inhalacion con una sal tiotropio ECSP034570A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10054042 2000-10-31

Publications (1)

Publication Number Publication Date
ECSP034570A true ECSP034570A (es) 2003-06-25

Family

ID=7661727

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004570A ECSP034570A (es) 2000-10-31 2003-04-28 Formulacion de una solucion de inhalacion con una sal tiotropio

Country Status (32)

Country Link
EP (1) EP1335729A2 (es)
JP (1) JP4559703B2 (es)
KR (1) KR100983208B1 (es)
CN (1) CN1237970C (es)
AR (1) AR038765A1 (es)
AU (2) AU2002221741B2 (es)
BG (1) BG66425B1 (es)
BR (1) BR0115016A (es)
CA (1) CA2427583C (es)
CZ (1) CZ305033B6 (es)
DE (1) DE10152369A1 (es)
EA (1) EA009068B1 (es)
EC (1) ECSP034570A (es)
EE (1) EE05343B1 (es)
HR (1) HRP20030337A2 (es)
HU (1) HUP0301377A3 (es)
IL (2) IL155676A0 (es)
ME (1) ME00242B (es)
MX (1) MXPA03003750A (es)
MY (1) MY132777A (es)
NO (1) NO332524B1 (es)
NZ (1) NZ526024A (es)
PE (1) PE20020518A1 (es)
PL (1) PL361001A1 (es)
SA (1) SA01220503B1 (es)
SK (1) SK288031B6 (es)
TW (1) TWI296934B (es)
UA (1) UA76435C2 (es)
UY (1) UY26991A1 (es)
WO (1) WO2002036591A2 (es)
YU (1) YU33103A (es)
ZA (1) ZA200303045B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083800A2 (en) 2000-04-28 2001-11-08 Kosan Biosciences, Inc. Heterologous production of polyketides
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2544611A1 (en) * 2003-10-09 2005-04-21 Inverseon, Inc. Method of treating airway diseases with beta-adrenergic inverse agonists
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
SI1863476T1 (sl) * 2005-03-16 2016-05-31 Meda Pharma Gmbh & Co. Kg Kombinacija antiholinergikov in antagonistov receptorja levkotriena za zdravljenje respiratornih bolezni
AU2007267523B2 (en) * 2006-05-26 2012-02-09 Dey, L.P. Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
CN100446770C (zh) * 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 丙酸培氯米松水雾剂
TR200907237A2 (tr) * 2009-09-23 2011-04-21 B�Lg�� Mahmut Tiotropyum kuru toz kombinasyonu
CN111936124A (zh) * 2018-07-26 2020-11-13 四川海思科制药有限公司 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
CN116196298A (zh) * 2018-07-26 2023-06-02 四川海思科制药有限公司 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
BR9609307B1 (pt) * 1995-06-27 2010-03-09 preparação farmacêutica para produção de aerossóis inaláveis isentos de propelentes para administração nos pulmões, bem como aerossol compreendendo a mesma.
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
CA2256721A1 (en) * 1996-06-04 1997-12-11 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
ATE234604T1 (de) * 1998-08-04 2003-04-15 Jago Res Ag Medizinische aerosolformulierungen
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
AU2174102A (en) 2002-05-15
CN1237970C (zh) 2006-01-25
NO20031914D0 (no) 2003-04-29
UY26991A1 (es) 2002-06-20
EA009068B1 (ru) 2007-10-26
SK288031B6 (sk) 2012-12-03
YU33103A (sh) 2006-05-25
JP4559703B2 (ja) 2010-10-13
EE200300202A (et) 2003-10-15
MY132777A (en) 2007-10-31
CA2427583A1 (en) 2002-05-10
IL155676A0 (en) 2003-11-23
EA200300483A1 (ru) 2003-12-25
AR038765A1 (es) 2005-01-26
JP2004523482A (ja) 2004-08-05
WO2002036591A2 (de) 2002-05-10
CZ20031487A3 (cs) 2003-09-17
HRP20030337A2 (en) 2005-04-30
SK5262003A3 (en) 2003-10-07
ZA200303045B (en) 2004-04-22
PE20020518A1 (es) 2002-07-12
HUP0301377A2 (hu) 2003-10-28
MEP40708A (en) 2011-02-10
BR0115016A (pt) 2005-05-03
AU2002221741B2 (en) 2007-04-05
NO20031914L (no) 2003-06-23
ME00242B (me) 2011-05-10
TWI296934B (en) 2008-05-21
BG66425B1 (bg) 2014-04-30
KR20040010552A (ko) 2004-01-31
IL155676A (en) 2012-05-31
EP1335729A2 (de) 2003-08-20
DE10152369A1 (de) 2002-05-08
MXPA03003750A (es) 2004-10-15
WO2002036591A3 (de) 2002-07-25
NO332524B1 (no) 2012-10-08
NZ526024A (en) 2005-10-28
CZ305033B6 (cs) 2015-04-08
SA01220503B1 (ar) 2007-03-10
BG107726A (bg) 2004-11-30
CA2427583C (en) 2008-02-12
KR100983208B1 (ko) 2010-09-20
CN1473044A (zh) 2004-02-04
PL361001A1 (en) 2004-09-20
EE05343B1 (et) 2010-10-15
HK1060569A1 (en) 2004-08-13
UA76435C2 (en) 2006-08-15
HUP0301377A3 (en) 2005-12-28

Similar Documents

Publication Publication Date Title
CO5640070A2 (es) Formulacion para un inhalador con dosis medida que emplea hidrofluoroalcanos como propulsores
DE60308997D1 (de) Formulierungen zur inhalation
CU23260B7 (es) PREPARADO FARMACéUTICO DE MOXIFLOXACINA
HRP20030276B1 (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
UY30440A1 (es) Nuevos compuestos
EA200300503A1 (ru) Новые лекарственные композиции на основе солей тиотропия и солей салметерола
ECSP045221A (es) Sales de valsartan
CY1107825T1 (el) Εισπνεομενα σκευασματα τυπου διαλυματος με αλαστιοτροπιου
UY26991A1 (es) Formulación en solución inhalable con una sal de tiotropio
SV2006002274A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
AR029795A1 (es) Derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico sustituidos, procedimientos para su preparacion, su uso para la preparacion de medicamentos y medicamentos que contienen estos compuestos
EA200401303A1 (ru) Лекарственные средства, содержащие стероиды и новое антихолинергическое средство
UY27754A1 (es) Formulación de aerosol para inhalación que contiene una sal de tiotropio.
UY27324A1 (es) Nuevas sales de napsilato i
TR200600987T1 (tr) 7-karboksimetiloksi-3',4',5-trimetoksi flavon-monohidrat, hazırlama metodu ve kullanılması
AR063597A1 (es) Nueva sal
BR0107483A (pt) Processo para a preparação de um composto
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
BRPI0300660B8 (pt) método para quantificar liberação mitocondrial de citocromo c e kit para detectar liberação mitocondrial de citocromo c
CO4750644A1 (es) Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor